Health Care • Managed Health Care
$1.40 ▼ -0.18
(-11.37%)
MKT CAP: $2.2M • VOL: 28.8K
52W L $1 52W H $31
ROARABLE / RQD
D • 44/100
PIOTROSKI
2 / 9
BRTX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $359.7K | $401.0K | $145.8K |
| YoY Revenue Growth % | -10.3% | +175.0% | — |
| Gross Profit | $335.9K | $372.9K | — |
| Gross Margin % | 93.4% | 93.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$15.6M | -$11.6M | -$15.2M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$14.2M | -$9.0M | -$10.4M |
| EBITDA (Normalized) | -$15.6M | -$11.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$10.8M | -$8.2M | -$6.4M |
| Capital Expenditures (CapEx) | $116.1K | $106.2K | — |
| Free Cash Flow (FCF) | -$10.9M | -$8.3M | -$6.4M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $1.5M | $547.9K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $356.7K | $8.5M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BRTX.